Antimicrobial Resistance (AMR)
The Trillion-Dollar Bug: How AI and New Financial Models Are Fuelling the War on Superbugs
A new GSK-backed venture uses AI and innovative financial models to combat the growing economic and health threat of drug-resistant superbugs.